Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.730
+0.410 (31.06%)
At close: May 13, 2025, 4:00 PM
1.700
-0.030 (-1.73%)
After-hours: May 13, 2025, 4:27 PM EDT

Humacyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
268650294218747131
Upgrade
Market Cap Growth
-28.59%120.90%35.19%-70.86%471.21%-
Upgrade
Enterprise Value
2217092519754939
Upgrade
Last Close Price
1.325.052.842.117.2510.17
Upgrade
PS Ratio
396.05--139.03591.2787.68
Upgrade
PB Ratio
5.68-12.3421.721.866.111.85
Upgrade
P/TBV Ratio
5.68-21.721.866.11-
Upgrade
EV/Sales Ratio
427.69--61.82434.3125.88
Upgrade
Debt / Equity Ratio
2.20-1.544.290.430.420.41
Upgrade
Asset Turnover
0.00--0.010.010.01
Upgrade
Quick Ratio
3.142.254.367.7620.423.57
Upgrade
Current Ratio
3.682.404.517.8820.763.69
Upgrade
Return on Equity (ROE)
-249.75%--169.81%-10.01%-27.46%-65.58%
Upgrade
Return on Assets (ROA)
-42.82%-53.74%-36.44%-21.54%-25.81%-29.32%
Upgrade
Return on Capital (ROIC)
-63.65%-142.57%-50.66%-31.01%-37.20%-31.18%
Upgrade
Earnings Yield
-37.93%-22.88%-37.66%-5.50%-3.55%-50.88%
Upgrade
FCF Yield
--15.34%-25.70%-33.17%-10.90%-42.75%
Upgrade
Buyback Yield / Dilution
-18.75%-14.56%-0.36%-157.82%-593.25%71.34%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q